Effect of phototherapy on cardiorespiratory activity during sleep in neonates with physiologic jaundice

David Bader1, Amir Kugelman, Dan E Blum

  • 1Department of Neonatology, Bnai Zion Medical Center, Haifa, Israel. alona500@netvision.net.il

Insights

Phototherapy for neonatal jaundice alters cardiorespiratory activity during active sleep in term infants. These changes, including decreased respiratory rate, are not clinically significant during quiet sleep or in real-world conditions.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Sleep Medicine

Background:

  • Phototherapy is the standard treatment for neonatal jaundice.
  • Short-term cardiorespiratory effects of phototherapy require further investigation.

Purpose of the Study:

  • To evaluate the cardiorespiratory impact of phototherapy during sleep in term infants with physiologic jaundice.

Main Methods:

  • Two polysomnography studies were conducted on 10 healthy term infants during sleep.
  • Infants served as their own controls, with studies performed before and during phototherapy.
  • Cardiorespiratory parameters, including heart rate, respiratory rate, and apnea, were analyzed during active and quiet sleep.

Main Results:

  • Phototherapy led to a significant decrease in respiratory rate and an increase in heart rate during active sleep (P < 0.05).
  • No significant differences in cardiorespiratory parameters were observed during quiet sleep.
  • Oxygen saturation, apnea rate, and periodic breathing remained unaffected; no clinically significant apnea or bradycardia occurred.

Conclusions:

  • Phototherapy influences cardiorespiratory activity during active sleep in term infants with jaundice.
  • These observed effects do not appear to have clinical significance in practical settings.
Abstract

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...